CEPI announces call for proposals to innovate vaccines

A yellow fever vaccine manufacturing facility at the Val de Reuil Sanofi Pasteur site in France. Photo by: Sanofi Pasteur / CC BY-NC-ND

WASHINGTON  — With a call for proposals on Tuesday, the Coalition for Epidemic Preparedness Innovations aims to shorten the usually long time it takes to develop vaccines for emerging diseases.

This call, open to a range of companies, foundations and research and development institutions, asks for ideas for “new approaches to vaccine development” that will “support the development of rapid response platforms for vaccine development, a core part of CEPI’s mission,” Richard Hatchett, the CEO of CEPI told Devex.

CEPI is a partnership founded by the governments of India and Norway, the Bill & Melinda Gates Foundation, the Wellcome Trust and the World Economic Forum that was founded in 2016.

Coalition for Epidemic Preparedness Innovations launches in Davos

A new initiative backed by nearly half a billion dollars will finance vaccine research and other innovations to combat diseases that pose global health security threats.

The technologies or platforms that CEPI seeks in this call will speed the pace of vaccine development and create fast-acting vaccines that can be scaled rapidly. The focus will be on vaccine development for emerging epidemics, including for pathogens or diseases that are not yet on the public health radar.

This article is for Devex Members

For full access to the content of the article sign in or join Devex.

About the author

  • Saldiner adva

    Adva Saldinger

    Adva Saldinger is an Associate Editor at Devex, where she covers the intersection of business and international development, as well as U.S. foreign aid policy. From partnerships to trade and social entrepreneurship to impact investing, Adva explores the role the private sector and private capital play in development. A journalist with more than 10 years of experience, she has worked at several newspapers in the U.S. and lived in both Ghana and South Africa.